xtandi
astellas pharma europe b.v. - enzalutamida - neoplasmas prostáticos - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
enzalutamida 40 mg
lotus pharmaceuticals co. ltd - enzalutamida - cápsula blanda - 40 mg
xtandi cápsula blanda
adium pharma (distribuido por nolver s.a. en la rou fuera de zona franca) - cápsula blanda - enzalutamida 40 mg cápsula
zalutex cápsula
urufarma - cápsula - enzalutamida 40 mg cápsula
enzalutamida cápsulas 40 mg
remus pharmaceuticals pvt. ltd. india - enzalutamida 40 mg - capsulas - cada cápsula contiene: enzalutamida 40 mg
karkino cápsulas 40mg
gliesse pharmaceutical pvt. ltd. india - enzalutamida 40mg/capsula - capsula - cada cápsula de gelatina dura contiene: enzalutamida 40mg
xtandi 40 mg capsulas blandas
astellas pharma us inc. estados unidos - enzalutamida 40,00mg - cÁpsulas blandas - cada cÁpsula blanda contiene: enzalutamida 40,00mg
enzalutamida 40 mg capsulas
psicofarma s.a. [ec] ecuador - enzalutamida 40 mg - capsulas de gelatina dura - cada cápsula de gelatina dura contiene: enzalutamida* 40.00 mg
zapurid? 40 mg
sandoz gmbh austria - enzalutamida 40 mg - capsulas blandas - cada capsula contiene: enzalutamida 40 mg
zalutex
laboratorio elea phoenix s.a. argentina - enzalutamida 40 mg - capsulas duras - cada cÁpsula dura contiene: enzalutamida 40 mg